Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Should GlaxoSmithKline Have Accepted Unilever's $68 Billion Consumer Health Offer?

TheMotleyFool

0 0

Should GlaxoSmithKline Have Accepted Unilever's $68 Billion Consumer Health Offer?

Thanks, but no thanks. That was basically the response from GlaxoSmithKline (NYSE: GSK) to Unilever's (NYSE: UL) recent offer to buy its joint venture consumer health unit for $68 billion. In this Motley Fool Live video recorded on Jan. 19, Motley Fool contributors Keith Speights and Brian Orelli discuss whether they think GlaxoSmithKline should have accepted Unilever's offer.

Source Fool.com

Like: 0

GSK

Share